MedPath

Caries prevention around the orthodontic appliance

Not Applicable
Conditions
Tooth desmineralization, Dental Caries, white spot
3745
Registration Number
RBR-2b2vvf5
Lead Sponsor
São Leopoldo Mandic
Brief Summary

For the group treated with the Icon ® resinous infiltrant, the ICDAS index values remained stable, T0 (application of the resinous infiltrant) (M = 0.062; SD = 0.162), T1 (six months after application) (M = 0.062; SD = 0.162) and T2 (one year after application) (M = 0.073; SD = 0.164) and showed no statistical differences (p = 0.500). For the control group (fluoride-free placebo agent) there were significant variations over time (p <0.001), with average increases at all times evaluated (p <0.001).

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Age between 12 and 20 years; incisors, canines and premolars present in the arch, all with a healthy buccal surface at the beginning of orthodontic treatment; ICDAS greater than 2; no history of previous orthodontic treatment.

Exclusion Criteria

Abuse of any type of medication, alcohol, nicotine or other types of drugs; systemic, metabolic or mental illness; craniofacial syndrome, cleft lip and / or palate.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ability of the resinous infiltrant (Icon) to prevent the formation of a white spot lesion (tooth demineralization) obtained in scores (ordinal categorical variable with 7 categories), through the International Caries Detection and Assessment System (ICDAS), when compared to a group in which no intervention was performed (control group).;Capacity of the resinous infiltrant (Icon) to prevent the formation of white spot lesions (dental demineralization) during one year of follow-up, obtained in scores (ordinal categorical variable with 7 categories), through the International Caries Detection and Assessment System index ( ICDAS), verified six months (T1) and one year (T2) after application of the resinous infiltrate (T0).
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes are not expected.;Secondary outcomes are not expected.
© Copyright 2025. All Rights Reserved by MedPath